Article

RNF213 gene mutation of circulating tumor DNA in early diagnosis of NSCLC using targeted next-generation sequencing

2019-07-16

Abstract excerpt

<h4>Introduction: </h4> To distinguish early stage lung cancer from benign disease of the lung nodules, especially the lesions with ground-glass opacity (GGO) or ground-glass nodule (GGN), we assessed gene mutations of the ctDNA in peripheral blood by using targeted next-generation sequencing (NGS). Methods Single lung nodule patients without mediastinal lymph nodes or symptoms hardly diagnosed by chest CT and b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2cf0b992-e232-5b31-88d0-f1d78f02579b
DOI: 10.21203/rs.2.11443/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

RNF213 gene mutation of circulating tumor DNA in early diagnosis of NSCLC using targeted next-generation sequencingDOI 10.21203/rs.2.11443/v1Read

RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.Semantic proximity Read

Multi-Center Study of Resectable Lung Lesions by Ultra-Deep Sequencing of Targeted Genes in Plasma Cell-Free DNA to Assess Nodule Malignancy and Detect Lung CancersSemantic proximity Read

Recent advance of next-generation sequencing in patients with lung cancer.Semantic proximity Read

Next-Generation Sequencing in Lung Cancers-A Single-Center Experience in Taiwan.Semantic proximity Read

Analysis of NTRK mutation and clinicopathologic factors in lung cancer patients in northeast China.Semantic proximity Read

The Early Diagnosis in Lung Cancer by the Detection of Circulating Tumor DNASemantic proximity Read

Genomics and the early diagnosis of lung cancerSemantic proximity Read

The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients.Semantic proximity Read

Genetic Markers in Lung Cancer Diagnosis: A ReviewSemantic proximity Read

Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLCSemantic proximity Read

Utility of Cell-Free DNA from Bronchoalveolar Lavage Fluids Using Next Generation Sequencing in Predicting Malignant Solitary Pulmonary NodulesSemantic proximity Read

Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNASemantic proximity Read